Keywords: Cerenis, Novasep, French government funding, CER-001, Financing

Cerenis and Novasep get 10.7 million-euro funding from the French government for the development of CER-001

Article | 27 July 2010

French companies Cerenis Therapeutics, which is developing novel high-density lipoprotein (HDL) therapies to treat cardiovascular and other metabolic diseases, and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Novasep

Go to company listing